Related Experiment Video
Updated: May 13, 2026
05:44
Rodent Inferior Vena Cava Venoplasty Balloon Model
Published on: May 24, 2024
Contraception, venous thrombosis and biological plausability
1Coagulation Center "Rhein‑Ruhr" Duisburg, Germany. hannelore.rott@gzrr.de
Minerva Medica
|March 22, 2013
Summary
Combined oral contraceptives (COCs) vary in venous thromboembolism (VTE) risk based on progestogen type and estrogen dose. Second-generation COCs are recommended to minimize VTE risk, while progestogen-only methods are safer for high-risk patients.
Area of Science:
- Endocrinology
- Thrombosis
- Pharmacology
Background:
- Hormone therapy impacts coagulation differently; estrogen typically activates it, while progestogens alone do not.
- Combined oral contraceptives (COCs) exhibit varying risks for venous thromboembolism (VTE) dependent on estrogen content and progestogen type.
Purpose of the Study:
- To analyze the VTE risk associated with different generations and formulations of COCs.
- To evaluate the safety of progestogen-only contraceptives in patients with VTE history or thrombophilic defects.
- To compare the coagulation activation potential of newer estrogen-based COCs with traditional ethinyl-estradiol containing COCs.
Main Methods:
- Comparative analysis of VTE risk data for various COC formulations (2nd, 3rd, 4th generation, transdermal, vaginal ring).
- Review of contraindications and safety profiles of contraceptive methods in patients with thrombotic risks.
- Assessment of coagulation activation markers in users of ethinyl-estradiol (EE) versus estradiol-based COCs.
Main Results:
- Third and fourth-generation COCs with desogestrol, gestoden, or drospirenone, and transdermal/vaginal formulations, show higher VTE risk than second-generation COCs (levonorgestrel, norethisterone).
- Progestogen-only contraceptives generally do not significantly increase VTE risk and are suitable for patients with VTE history or thrombophilia.
- Newer COCs utilizing estradiol valerate or estradiol demonstrate reduced coagulation activation compared to traditional EE-containing COCs.
Conclusions:
- Second-generation COCs are recommended as the primary choice for hormonal contraception due to lower VTE risk.
- Progestogen-only contraceptives offer a safe alternative for women at high risk for VTE.
- Further research is needed to determine the actual VTE risk of newer estradiol-based COCs.
Related Concept Videos
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:22Birth Control Methods
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although vasectomy...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...